Trade Summary

3 days ago, Cormorant Asset Management, LP, serving as Former 10% owner Owner at Bright Minds Biosciences Inc. (DRUG), sold 109,331 shares at $89.50 per share, for a total transaction value of $9,785,125.00. Following this transaction, Cormorant Asset Management, LP now holds 950,000 shares of DRUG.

This sale represents a 10.00% decrease in Cormorant Asset Management, LP's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, April 28, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, April 30, 2026, 2 days after the trade was made.

Bright Minds Biosciences Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.